Orion Biotech Opportunities Quick Ratio (ORIA) starting from the fourth quarter 2022 to fourth quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Orion Biotech Opportunities Corp   (NASDAQ: ORIA)
    Sector • Financial    Industry • Blank Checks
   Industry • Blank Checks
   Sector • Financial

Orion Biotech Opportunities 's Quick Ratio

ORIA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2022, Quick Ratio fell to 3.93 a new company low.

Within Blank Checks industry 18 other companies have achieved higher Quick Ratio than Orion Biotech Opportunities in fourth quarter 2022. While Quick Ratio total ranking in the fourth quarter 2022 has deteriorated compared to the prior quarter from 706 to 991.

Explain Quick Ratio?
How much Cash & cash equivalents ORIA´s has?
What are ORIA´s Current Liabilities?




ORIA Quick Ratio (Dec 31 2022)
Q4
(Sep 30 2022)
Q3
(Jun 30 2022)
Q2
(Mar 31 2022)
Q1
(Dec 31 2021)
Q4
Y / Y Current Liabilities Change -98.42 % -30.05 % -58.79 % 497.03 % -
Y / Y Cash & cash equivalent Change -62.71 % -56.3 % -52.48 % - -
Quick Ratio MRQ 3.93 5.88 10.39 0.32 0.17
ORIA's Total Ranking # 991 # 706 # 397 # 762 # 482
Seq. Current Liabilities Change 16.55 % 43.92 % -97.74 % -58.36 % 5058.09 %
Seq. Cash & cash equivalent Change -22.08 % -18.52 % -27.32 % -19.17 % -8.71 %



Quick Ratio fourth quarter 2022 Company Ranking
Within: No.
Blank Checks Industry # 19
Financial Sector # 154
Overall Market # 991


Quick Ratio Statistics
High Average Low
10.39 7.51 3.93
(Jun 30 2022)   (Dec 31 2022)




Financial Statements
Orion Biotech Opportunities 's Current Liabilities $ 0 Millions Visit ORIA's Balance sheet
Orion Biotech Opportunities 's Cash & cash equivalent $ 0 Millions Visit ORIA's Balance sheet
Source of ORIA's Sales Visit ORIA's Sales by Geography


Cumulative Orion Biotech Opportunities 's Quick Ratio

ORIA's Quick Ratio for the trailling 12 Months

ORIA Quick Ratio

(Dec 31 2022)
12 Months
(Sep 30 2022)
12 Months
(Jun 30 2022)
12 Months
(Mar 31 2022)
12 Months
(Dec 31 2021)
12 Months
Y / Y Current Liabilities TTM Growth -59.07 % 1185.17 % 1460.49 % 1991.38 % -
Y / Y Cash & cash equivalent TTM Growth -32.54 % 23.29 % 182.43 % - -
Quick Ratio TTM 0.82 0.33 0.4 0.47 0.5
Total Ranking TTM # 4324 # 4237 # 4190 # 4176 # 360
Seq. Current Liabilities TTM Growth -68.38 % -0.4 % -0.92 % 31.17 % 892.86 %
Seq. Cash & cash equivalent TTM Growth -21.81 % -17.67 % -15.67 % 24.26 % 42.89 %


On the trailing twelve months basis Current Liabilities decreased faster than Orion Biotech Opportunities 's average Cash & cash equivalent, this led to increase in in Orion Biotech Opportunities 's Quick Ratio to 0.82, Quick Ratio remained below ORIA average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Blank Checks industry 223 other companies have achieved higher Quick Ratio than Orion Biotech Opportunities . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2022 from 4237 to 4324.

Explain Quick Ratio?
How much Cash & cash equivalents ORIA´s has?
What are ORIA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Blank Checks Industry # 224
Financial Sector # 370
Within the Market # 4324


trailing twelve months Quick Ratio Statistics
High Average Low
7.92 7.18 5.8
(Mar 31 2022)   (Dec 31 2022)




Companies with similar Quick Ratio in the quarter ending Dec 31 2022, within Blank Checks Industry Quick RatioDec 31 2022 MRQ Cash & cash equivalentDec 31 2022 MRQ Current Liabilities
Cartica Acquisition Corp  10.50 $ 1.081  Millions$ 0.103  Millions
Piermont Valley Acquisition Corp   9.69 $ 0.969  Millions$ 0.100  Millions
Shuaa Partners Acquisition Corp I  8.09 $ 0.644  Millions$ 0.080  Millions
Newhold Investment Corp Ii  6.85 $ 0.986  Millions$ 0.144  Millions
Alsp Orchid Acquisition Corporation I  4.80 $ 0.211  Millions$ 0.044  Millions
Arvana Inc   4.78 $ 0.142  Millions$ 0.030  Millions
Orion Biotech Opportunities Corp   3.93 $ 0.266  Millions$ 0.068  Millions
Cartesian Growth Corporation Ii  3.65 $ 0.544  Millions$ 0.149  Millions
Chain Bridge I  3.58 $ 0.116  Millions$ 0.033  Millions
Dp Cap Acquisition Corp I  2.82 $ 0.946  Millions$ 0.335  Millions
Enterprise 4 0 Technology Acquisition Corp   2.76 $ 0.136  Millions$ 0.049  Millions
Healthcare Ai Acquisition Corp   2.58 $ 0.401  Millions$ 0.156  Millions
Embrace Change Acquisition Corp   2.57 $ 0.403  Millions$ 0.157  Millions
Libity  2.55 $ 0.636  Millions$ 0.249  Millions
Waverley Capital Acquisition Corp 1  2.46 $ 1.108  Millions$ 0.451  Millions
Pmv Consumer Acquisition Corp   2.35 $ 1.149  Millions$ 0.490  Millions
Chenghe Acquisition I Co   2.26 $ 1.103  Millions$ 0.488  Millions
Skydeck Acquisition Corp   2.20 $ 0.888  Millions$ 0.404  Millions
Relativity Acquisition Corp  2.16 $ 1.430  Millions$ 0.662  Millions
Concord Acquisition Corp Ii  2.14 $ 1.081  Millions$ 0.505  Millions
Integral Acquisition Corporation 1  2.10 $ 0.601  Millions$ 0.286  Millions
C5 Acquisition Corporation  2.09 $ 0.936  Millions$ 0.448  Millions
Conyers Park Iii Acquisition Corp   2.02 $ 2.114  Millions$ 1.048  Millions
Hainan Manaslu Acquisition Corp   2.00 $ 0.073  Millions$ 0.037  Millions
Tristar Acquisition I Corp   1.97 $ 0.588  Millions$ 0.298  Millions
Crescera Capital Acquisition Corp   1.97 $ 0.619  Millions$ 0.315  Millions
Kensington Capital Acquisition Corp V  1.83 $ 1.236  Millions$ 0.676  Millions
Pearl Holdings Acquisition Corp  1.81 $ 0.411  Millions$ 0.227  Millions
Hhg Capital Corporation  1.77 $ 0.329  Millions$ 0.186  Millions
Blue Whale Acquisition Corp I  1.74 $ 1.737  Millions$ 0.998  Millions

Date modified: 2026-06-22T16:30:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.